Gene · 4825
Papers1,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LINC MIR503HG Controls SC-β Cell Differentiation and Insulin Production by Targeting CDH1 and HES1. | Adv Sci (Weinh) | 2024 | 38243869 | PubTator, text mining | PubMed |
| Sox9 regulates alternative splicing and pancreatic beta cell function. | Nat Commun | 2024 | 38238288 | PubTator, text mining | PubMed |
| Permanent neonatal diabetes-causing insulin mutations have dominant negative effects on beta cell identity. | Mol Metab | 2024 | 38237895 | PubTator, text mining | PubMed |
| PRADclass: Hybrid Gleason Grade-Informed Computational Strategy Identifies Consensus Biomarker Features Predictive of Aggressive Prostate Adenocarcinoma. | Technol Cancer Res Treat | 2024 | 38226611 | PubTator, text mining | PubMed |
| N-acetyltransferase NAT10 controls cell fates via connecting mRNA cytidine acetylation to chromatin signaling. | Sci Adv | 2024 | 38215194 | PubTator, text mining | PubMed |
| HAMSAB diet ameliorates dysfunctional signaling in pancreatic islets in autoimmune diabetes. | iScience | 2024 | 38213620 | PubTator, text mining | PubMed |
| Regulation of multiple signaling pathways promotes the consistent expansion of human pancreatic progenitors in defined conditions. | Elife | 2024 | 38180318 | PubTator, text mining | PubMed |
| Non-canonical non-genomic morphogen signaling in anucleate platelets: a critical determinant of prothrombotic function in circulation. | Cell Commun Signal | 2024 | 38172855 | PubTator, text mining | PubMed |
| Metabolic switching, growth kinetics and cell yields in the scalable manufacture of stem cell-derived insulin-producing cells. | Stem Cell Res Ther | 2024 | 38167219 | PubTator, text mining | PubMed |
| EZH2 inhibitors promote β-like cell regeneration in young and adult type 1 diabetes donors. | Signal Transduct Target Ther | 2024 | 38161208 | PubTator, text mining | PubMed |
| Insulin regulates human pancreatic endocrine cell differentiation in vitro. | Mol Metab | 2024 | 38103636 | PubTator, text mining | PubMed |
| Silencing hsa_circ_0032449 inhibits the pancreatic differentiation of human embryonic stem cells via the hsa_miR-195-5p/CCND1/PI3K/AKT signaling pathway. | Exp Cell Res | 2024 | 38072304 | PubTator, text mining | PubMed |
| PPY-cell hyperplasia accompanying NENs: Immunohistochemical and nuclear medicine analysis. | Pathol Res Pract | 2024 | 38000200 | PubTator, text mining | PubMed |
| A simple tool for the synchronous differentiation of human induced pluripotent stem cells into pancreatic progenitors. | Biotechnol J | 2024 | 37955342 | PubTator, text mining | PubMed |
| Adjudin improves beta cell maturation, hepatic glucose uptake and glucose homeostasis. | Diabetologia | 2024 | 37843554 | PubTator, text mining | PubMed |
| Epigenetic modulation of cell fate during pancreas development. | Trends Dev Biol | 2023 | 38873037 | PubTator, text mining | PubMed |
| Transmission-selective muscle pathology induced by the active propagation of mutant huntingtin across the human neuromuscular synapse. | Front Mol Neurosci | 2023 | 38235149 | PubTator, text mining | PubMed |
| CEMIG: prediction of the cis-regulatory motif using the de Bruijn graph from ATAC-seq. | Brief Bioinform | 2023 | 38189539 | PubTator, text mining | PubMed |
| Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a "Trojan Horse". | Int J Mol Sci | 2023 | 38139149 | PubTator, text mining | PubMed |
| Retinoids: Mechanisms of Action in Neuronal Cell Fate Acquisition. | Life (Basel) | 2023 | 38137880 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4825/papers?page=5